<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<title>人民医院——科教管理</title>
<script language="javascript">
var tid=41 ;
var sid=41 ;
</script>
<meta name="keywords" content="医院，红十字，健康，专家，科研，教学，论文，研究生，学术，下载，获奖成果，进修，继续教育，住院医师
">
<link rel="stylesheet" type="text/css" href="../../images/kygz.css">
</head>
<body>
<div class="wrapper">
    <div class="header">
        <div class="hea_up">
            <div class="logo"><img src="../../images/ky_logo.jpg" width="455" height="127"></div>
            <div class="search">
                <form id="productSearch" method="post" action="/List/News" name="Search">
                <div class="ss_a">
                <input id="search_text" type="text" name="key">
                </div>
                <div class="ss_b"><img id="btnsearch" style="cursor:pointer;" src="../../images/ss_anniu.jpg" width="49" height="25" border="0" onclick="if(Search.key.value==''){alert('请输入关键字!');}else{productSearch.submit();}">
                </div>
		</form>
            </div>
        </div>
        <div class="nav">
            <script type="text/javascript" src="../../infor/js/31-0.js"></script>
        </div>
    </div>
    <div class="banner">
        <div class="ksdh">
            <ul>
            <li><a href="../../List/News/163.html">查询系统</a></li>
            <li><a href="../../content/detail/c242.html">GCP入口</a></li>
            <li><a href="javascript:window.open('https://www.firsthospital.cn/List/News/437');">医学伦理</a></li>
            </ul>
        </div>
    </div>
    <div class="main">
        <div class="zb_con">
            <div class="left_menu_bt">科技动态</div>    
	    <div class="left_menu_nr" id="leftmenu">
                <script src="https://www.firsthospital.cn/Execute/Module/52/0" type="text/javascript" ></script>
            </div>
        </div>
        <div class="right">
                 <div class="right_bt">
           <strong>您现在的位置：</strong>
           <a href="../../home/index.html">首页</a>>><a href='../../kjgl/index.html'>科教管理</a>>><a href='../../kjgl/index.html'>科研工作</a>>>科技动态
     </div>
     <div class="right_nr">
           <div class="xingfa_nr">
                 <div class="timu">核医学科临床研究项目启动会召开
		 </div>
		 <p><p align="center"><br></p><p align="center"><img alt="" src="../../upload/images/201803/20101401.jpg" border="0" vspace="0" hspace="-1"></p><p><font face="宋体" size="3">

<br></font></p><p style="margin: 0cm 0cm 0pt; line-height: 150%;"><span lang="EN-US" style="line-height: 150%; font-family: 宋体; font-size: 12pt; mso-ascii-theme-font: minor-fareast; mso-fareast-font-family: 宋体; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-fareast;">2</span><span style="line-height: 150%; font-family: 宋体; font-size: 12pt; mso-ascii-theme-font: minor-fareast; mso-fareast-font-family: 宋体; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-fareast;">月<span lang="EN-US">27</span>日，核医学科组织召开了申康系统专科疾病临床五新转化项目《锝<span lang="EN-US">-99m</span>标记<span lang="EN-US">PD-L1</span>抗体片段在非小细胞肺癌诊断中的临床研究》（项目经费<span lang="EN-US">50</span>万元）基础研究进展汇报及临床研究阶段启动会。出席会议的人员有：院科研处处长祝延红，院伦理委员会江一峰主任，院临床实验机构办丁雪鹰主任，核医学科赵晋华主任及临床研究团队，肿瘤中心王红霞主任及临床研究团队，放射性药物专业研发公司和迈生物负责人及科研团队。</span></p><span style="line-height: 150%; font-family: 宋体; font-size: 12pt; mso-ascii-theme-font: minor-fareast; mso-fareast-font-family: 宋体; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-fareast;"><p style="margin: 0cm 0cm 0pt; line-height: 150%;"><span lang="EN-US" style="line-height: 150%; font-family: 宋体; font-size: 12pt; mso-ascii-theme-font: minor-fareast; mso-fareast-font-family: 宋体; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-fareast;">PD-1/PD-L1</span><span style="line-height: 150%; font-family: 宋体; font-size: 12pt; mso-ascii-theme-font: minor-fareast; mso-fareast-font-family: 宋体; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-fareast;">免疫疗法，是除手术、放射治疗、化疗和标靶治疗常用癌症治疗方案之外的新一代疗法，<span lang="EN-US">PD-1/PD-L1</span>免疫疗法通过阻断<span lang="EN-US">PD-1/PD-L-1</span>信号通路使癌细胞死亡，具有治疗多种类型肿瘤的潜力，有望实质性改善患者的总生存期。目前国外已有几种药物上市，效果显著，而国内尚空白。核医学科联合肿瘤科、放射性药物研发专业公司合作应用放射性核素锝<span lang="EN-US">-99m</span>标记<span lang="EN-US">PD-L1</span>抗体片段在非小细胞肺癌诊断中的临床研究，开创非小细胞肺癌特异诊断的新方法，并为后续的靶向放射免疫治疗奠定基础，具有良好的临床应用转化前景。</span></p></span><p align="right" style="margin: 0cm 0cm 0pt; line-height: 150%;"><span style="line-height: 150%; font-family: 宋体; font-size: 12pt; mso-ascii-theme-font: minor-fareast; mso-fareast-font-family: 宋体; mso-fareast-theme-font: minor-fareast; mso-hansi-theme-font: minor-fareast;">（通讯员<span lang="EN-US">/</span>核医学科 汪太松）</span></p><p><font face="宋体" size="3">

<br></font></p>
           </div>
     </div>
     <p>&nbsp;</p>
<script language="javascript">
document.title = "核医学科临床研究项目启动会召开";
</script>
	</div>
    </div>   
    <div class="clear"></div> 
    </div>
    <div class="foot">
      <p>人民医院 版权所有</p>
    </div>
    
</body>
</html>
